Biggest News Aggregation in the World
📰 Statement Regarding News

Page 71 - Statement Regarding News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Statement Regarding. Real-time updates on events, politics, business and more.

China's Influence in South Asia: Vulnerabilities and Resilience in Four Countries - Carnegie Endowment for International Peace

Bangladesh, Maldives, Nepal, and Sri Lanka showcase the diversity of China’s engagement strategies in a very multidimensional region but also make clear that influencers across South Asia are learning from each other’s experiences with Chinese money and power.
Budhi Gandaki Nepal General Bangladesh General United States Tibet Autonomous Region White House

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

The Hackett Group, Inc.: Procurement Organizations Can Achieve Breakthrough Improvements by Embracing Digital Technology

The Hackett Group's New Digital World Class Standards Raise the Bar on Procurement Performance By fully embracing digital transformation, procurement organizations can achieve superior levels of efficiency
United States Gary Baker Global Communications Research Erik Dorr Hackett Group Hackett Group New Digital World Class

DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER

DGAP-News: Defence Therapeutics Inc. / Key word(s): Study29.09.2021 / 08:30 The issuer is solely responsible for the content of this announcement._________________________________________________________________CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASEDEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A...
British Columbia Sebastien Plouffe Defence Therapeutics Inc Distribution Services Defence Therapeutics Lifewater Media

Defence Therapeutics Inc.: Defence Therapeutics to Finalize Its Objectives to Initiate a Phase I Trial Against Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a biotechnology Company working on
United Kingdom British Columbia Sebastien Plouffe Defence Therapeutics Inc British Columbia Newsfile Corp Defence Therapeutics

Defence Therapeutics Inc.: Defence Therapeutics Selects the Best Eight Accum Variants to Optimize Its ADC Therapeutic

Vancouver, British Columbia--(Newsfile Corp. - August 18, 2021) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company"), is pleased to announce, that after a detailed and rigorous selection
Eteläuomen Läi United Kingdom British Columbia Daiichi Sankyo Sebastien Plouffe Defence Therapeutics Inc

DEFENCE THERAPEUTICS SELECTS THE BEST 8 ACCUM(TM) VARIANTS TO OPTIMIZE ITS ADC THERAPEUTIC

DGAP-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous18.08.2021 / 08:30 The issuer is solely responsible for the content of this announcement.CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASEDEFENCE THERAPEUTICS SELECTS THE BEST 8 ACCUMTM VARIANTS TO OPTIMIZE ITS ADC THERAPEUTICVancouver, BC, Canada, August 1...
Eteläuomen Läi British Columbia Daiichi Sankyo Sebastien Plouffe Defence Therapeutics Inc Cancer Center

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science